The Centers for Medicare & Medicaid Services today announced four concepts that states can use to promote health coverage options under Section 1332 of the Affordable Care Act: account-based subsidies; state-specific premium assistance; adjusted plan options; and risk stabilization strategies. Specifically, the agency said the concepts allow a state to direct public subsidies into defined-contribution, consumer-directed accounts to pay for health insurance premiums or other health care expenses; design a subsidy structure that meets the unique needs of its population; provide financial assistance for different types of health insurance plans; and more flexibility to implement reinsurance programs or high-risk pools. “CMS and the Department of the Treasury look forward to engaging with states on these waiver concepts, which illustrate concepts that the Administration supports and that fit within the framework outlined in section 1332 of the Affordable Care Act,” the agency said. The departments last month issued updated guidance for states seeking to waive certain ACA requirements under Section 1332 beginning in plan year 2020. 
 

Headline
The AHA July 31 provided comments to the Centers for Medicare & Medicaid Services on its interim final rule on Medicaid community engagement requirements.…
Headline
The Department of Labor July 22 released a proposed rule to modernize how group health plans deliver required disclosures. The proposal would create a safe…
Headline
The Centers for Medicare & Medicaid Services today released a proposed rule that would update Medicaid provider tax policies included in the July 2025…
Headline
The AHA provided comments July 21 to the Centers for Medicare & Medicaid Services on its proposed rule to modify policies governing Medicaid…
Headline
The U.S. District Court for the District of Maryland July 16 enjoined eight provisions from the Centers for Medicare & Medicaid Services’ 2027 notice of…
Headline
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…